Since Xarelto lawsuits were consolidated in December 2014, more than 1,700
lawsuits have been filed nationwide against Janssen Research and Development
and Bayer Healthcare Pharmaceuticals. Earlier in September, a monthly
status conference was held to determine the bellwether cases. Bellwether
trials are the first trials held in an MDL, and they are used as representative
case studies to determine how the rest of the litigation will be resolved.
Currently, two bellwether trials have been slated for August 2016 in the
Eastern District of Louisiana, with a third and a fourth trial taking
place in the Southern District of Texas and the Southern District of Mississippi
Each of these cases alleges that Xarelto caused them to suffer severe internal
bleeding and/or hemorrhagic strokes. According to the lawsuits, Xarelto
manufacturers knew of the higher risk of hemorrhaging and internal bleeding
– yet continued to market their drug without a known antidote. They
allege that the warning information in the drug's label is woefully
inadequate and fails to convey the serious and sometimes-deadly dangers
associated with using this drug.
What is Xarelto?
Xarelto is a anticoagulant that was approved for patients at risk of a
stroke or blood clot. The drug functions similarly to Heparin and Coumadin
– yet unlike these older anticoagulants, Xarelto is marketed as
needing little to no testing while taking the medication. Unfortunately,
unlike Heparin and Coumadin, there is no antidote for uncontrolled bleeding
associated with Xarelto. As a result, patients who do experience hemorrhaging
are at a significantly higher risk of bleeding to death.
More than 1 in 100 patients taking Xarelto will experience some type of
unconrolled bleeding, including blood in the urine, gastrointestinal bleeding,
and nosebleeds. If the bleeding is severe, doctors are helpless to stop
it. Since Xarelto was first released and approved by the FDA, more than
2,100 adverse reactions have been reported.
Bayer Healthcare Pharmaceuticals is one of the top fifteen companies in
the pharmaceutical market. They boast that more than 7 million people
around the world currently take Xarelto – even though there is no
known antidote. Patients have reported serious and often fatal side effects
after taking Xarelto, including:
- Pulmonary embolism
- Deep vein thrombosis
- Gastrointestinal hemorrhage
- Internal bleeding
- Brain bleeds
During the first eight months of 2013 alone, there were 968 reports of
serious Xarelto side effects and 72 Xarelto deaths. The year prior, there
were 750 reports of serious Xarelto side effects and 58 Xarelto deaths.
A Xarelto Lawyer Can Help
An experienced Xarelto attorney can help you determine whether your injuries
are the result of taking Xarelto. If your injury was caused by Xarelto,
your attorney can review all of your legal options with you and help you
choose the path that is right for you and your family. Many of the Xarelto
dangers are life-threatening, requiring emergency medical attention, lengthy
hospitalization, and ongoing treatment.